Cargando…
Hepatocellular Carcinoma in Asia: A Challenging Situation
Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal lookin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969322/ https://www.ncbi.nlm.nih.gov/pubmed/31988864 http://dx.doi.org/10.5005/jp-journals-10018-1292 |
_version_ | 1783489305351553024 |
---|---|
author | Jafri, Wasim Kamran, Muhammad |
author_facet | Jafri, Wasim Kamran, Muhammad |
author_sort | Jafri, Wasim |
collection | PubMed |
description | Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal looking livers on imaging. There are multiple risk factors for HCC, including hepatitis B and C infections, diabetes mellitus, alcohol, and nonalcoholic steatohepatitis. Other common risk factors which are known to be involved in the pathogenesis of HCC are obesity, food contaminated with aflatoxin and hemochromatosis. Many of these factors are commonly found in this part of the world, hence the high burden of disease. Besides these, smoking and familial predisposition to HCC also seem to have an important role to play in its development. Majority of HCC are missed at an early stage despite the emphasis on adequate screening and surveillance strategies. Therefore, most of the time these tumors are diagnosed at a fairly advanced stage, when palliative treatment is the only therapeutic option left. Hence, prevention of HCC by controlling and minimizing the possible risk factors is the need of the hour. How to cite this article: Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019; 9(1):27-33. |
format | Online Article Text |
id | pubmed-6969322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-69693222020-01-27 Hepatocellular Carcinoma in Asia: A Challenging Situation Jafri, Wasim Kamran, Muhammad Euroasian J Hepatogastroenterol Review Article Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal looking livers on imaging. There are multiple risk factors for HCC, including hepatitis B and C infections, diabetes mellitus, alcohol, and nonalcoholic steatohepatitis. Other common risk factors which are known to be involved in the pathogenesis of HCC are obesity, food contaminated with aflatoxin and hemochromatosis. Many of these factors are commonly found in this part of the world, hence the high burden of disease. Besides these, smoking and familial predisposition to HCC also seem to have an important role to play in its development. Majority of HCC are missed at an early stage despite the emphasis on adequate screening and surveillance strategies. Therefore, most of the time these tumors are diagnosed at a fairly advanced stage, when palliative treatment is the only therapeutic option left. Hence, prevention of HCC by controlling and minimizing the possible risk factors is the need of the hour. How to cite this article: Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019; 9(1):27-33. Jaypee Brothers Medical Publishers 2019 /pmc/articles/PMC6969322/ /pubmed/31988864 http://dx.doi.org/10.5005/jp-journals-10018-1292 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Article Jafri, Wasim Kamran, Muhammad Hepatocellular Carcinoma in Asia: A Challenging Situation |
title | Hepatocellular Carcinoma in Asia: A Challenging Situation |
title_full | Hepatocellular Carcinoma in Asia: A Challenging Situation |
title_fullStr | Hepatocellular Carcinoma in Asia: A Challenging Situation |
title_full_unstemmed | Hepatocellular Carcinoma in Asia: A Challenging Situation |
title_short | Hepatocellular Carcinoma in Asia: A Challenging Situation |
title_sort | hepatocellular carcinoma in asia: a challenging situation |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969322/ https://www.ncbi.nlm.nih.gov/pubmed/31988864 http://dx.doi.org/10.5005/jp-journals-10018-1292 |
work_keys_str_mv | AT jafriwasim hepatocellularcarcinomainasiaachallengingsituation AT kamranmuhammad hepatocellularcarcinomainasiaachallengingsituation |